-----BEGIN PGP SIGNED MESSAGE-----
Hash: SHA1
United States: Ground-breaking Federal District Court Ruling on Gene Patents
,----[ Quote ]
| Editor: Do you see any of your larger clients
| selling off some of their patent portfolios?
|
| Camacho: I see very few of my clients selling
| off patent assets except in connection with
| the sale of a portion of the business, which
| will typically include the portion of the
| patent portfolio to which it pertained. More
| often, my clients are finding strategic
| partnerships in which they can monetize their
| patent portfolio by licensing the technology
| in markets that are ancillary or orthogonal to
| the client's primary market - i.e., they don't
| want to license the technology to a
| competitor. However, when a client has a large
| number of overlapping patents on a particular
| product and the value of pushing through
| incremental advances on that particular
| product is marginal at best, I do see clients
| choosing to spend less of their IP budget on
| getting additional patent coverage.
`----
http://www.mondaq.com/unitedstates/article.asp?articleid=101018
Cancer gene patent faces legal challenge
http://news.smh.com.au/breaking-news-national/cancer-gene-patent-faces-legal-challenge-20100608-xriy.html
Recent:
Biotech industry warns about legal challenge
,----[ Quote ]
| ELEANOR HALL: Australia's biotechnology
| industry is warning that the court challenge
| being launched today against the patenting of
| human genetic material could kill off
| investment in the industry.
|
| Lawyers have begun legal action against four
| biotechnology companies, which co-own the
| patent to the breast cancer gene.
|
| They say companies shouldn't have the right
| to commercialise the human body.
|
| But representatives of the biotechnology
| industry say the landmark legal case could
| stifle innovation and investment in important
| medical research.
`----
http://www.abc.net.au/worldtoday/content/2010/s2921333.htm
Think Gene Patents Are Controversial Now? Just Wait
,----[ Quote ]
| Of course, the $1,000 genome is likely
| years away, and those who favor exclusive
| patents on diagnostics say theyâre
| necessary for companies to make their money
| back on research and development.
|
| But exclusive patents may already be
| keeping some patients in the dark, the WSJ
| article says. It describes a new method of
| genetic testing called chromosomal
| microarrays that can pick up chromosomal
| abnormalities in the genome. Whatâs a
| doctor to do if that kind of analysis
| encompasses a gene thatâs already patented
| â tell the patient or stick to the letter
| of the law?
`----
http://blogs.wsj.com/health/2010/04/14/think-gene-patents-are-controversial-now-just-wait/
-----BEGIN PGP SIGNATURE-----
Version: GnuPG v1.4.10 (GNU/Linux)
iEUEARECAAYFAkwYYd8ACgkQU4xAY3RXLo6xXwCYyn4ERkRYYUw8E2Nug5CiFsE0
mACfZ7Pil797jCSGoS8Ovm0UxKNpMpc=
=SG8q
-----END PGP SIGNATURE-----
|
|
